Why do you like that fact that we retail investors are unlikely to receive updates between quarterlies? As an investor do you not want to know growth in sales or projections for sales?
And don't tell me Mesoblast are too busy with 'work to do' - that's absolute rubbish. Mesoblast team would be acutely aware of every single patient enrolled and every change in future sales projections. They have a full time communications team. So how is it possible that they are too busy to provide this same information to retail investors.
Do you really believe that insiders & institutional investors like M&G, Thorney won't be getting answers about number of patients, success of treatments and projections?
As per usual with Mesoblast, the announcement released today was deliberately obfuscating. It would have taken more time and effort to draft such an ambiguous statement than it would have been to just provide the very basic numbers in a clear fashion.
MSB Price at posting:
$1.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)